Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath. The Swiss group has taken a license to use an antibody developed by ALZpath against a ...

Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to potentially identify the condition from other neurodegenerative disorders and ...

When running microservices in kubernetes. We need to handle the termination signals emitted by kubernets. The proper way of doing this is to: Listen to SIGINT, SIGTERM Upon receiving a signal, place ...

CARLSBAD, Calif., Nov. 6, 2025 /PRNewswire/ -- ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's disease, today announced it has been named the winner of the ...

Abu Dhabi is set to open the Middle East and North Africa’s first centre dedicated to the early biochemical detection of Alzheimer’s disease, offering advanced blood tests that can identify risk as ...

Region’s first Center for Advanced Neuro Biochemical Diagnostics to open in Abu Dhabi Abu Dhabi: In a major step towards reducing Alzheimer's cases in the UAE and beyond, a new world-class diagnostic ...

ABU DHABI, 16th April, 2025 (WAM) -- The National Reference Laboratory (NRL), part of the M42 Group, is establishing the MENA region's first Centre for Advanced Neuro Biochemical Diagnostics dedicated ...

The UAE is to open the region’s first centre to detect Alzheimer’s as early as the age of 40 through a simple blood test. In the race to detect the disease early, the new centre in Abu Dhabi - which ...